Type 1 Diabetes Mellitus and Premature Coronary Artery Disease

Dyah Ayu Ikeningrum, Djanggan Sargowo, Novi Kurnianingsih, Anna Fuji Rahimah

Abstract


Cardiovascular disease, which affects more than half of all diabetics, is the leading cause of morbidity and mortality in patients with type 1 and type 2 Diabetes Mellitus (DM). Around 55% of diabetes patients are thought to have it, in comparison to 2-4% of the general population. A significant risk factor for the development of Coronary Artery Disease (CAD) exists in people with Type 1 Diabetes Mellitus (T1DM). However, it is worth noting that the present Models of risk prediction for T1DM have a variety of flaws. CAD risk is expected to double or quadruple over the next two to four decades, and diabetes mellitus is the third most significant risk factor for the etiology of illness. As a result, diabetes increases the chance of developing Acute Coronary Syndromes (ACS), whose incidence surpasses 20% after seven years, compared to a rate of 3.5 percent in non-diabetics – a rate comparable to individuals who have already experienced an Acute Myocardial Infarction (AMI). Additionally, it is crucial to identify any well-defined specific risk factors for T1DM as well as any extra subclinical atherosclerosis that may influence these patients at an advanced stage of disease progression. T1DM patients have more severe lesions, a lower left ventricle (LV) ejection fraction, a higher risk of cardiac events, and a higher rate of silent ischemia when compared to non-diabetics. They continue to have impaired microcirculation and endothelial function, both of which contribute to tissue perfusion problems.


Keywords


Type 1 Diabetes Mellitus, Premature Coronary Artery Disease, Risk Factor

Full Text:

PDF

References


Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Poor Glycemic Control Predicts Coronary Heart Disease Events in Patients With Type 1 Diabetes Without Nephropathy. Vol 19.; 1999. http://www.atvbaha.org

Zgibor JC, Piatt GA, Ruppert K, Orchard TJ, Roberts MS. Deficiencies of cardiovascular risk prediction models for type 1 diabetes. Diabetes Care. 2006;29(8):1860-1865. doi:10.2337/dc06-0290

Yusuf S, Hawken S, Ôunpuu S, Dans T. yusuf2004, effect modified risk factor in ACS.

Zgibor JC, Piatt GA, Ruppert K, Orchard TJ, Roberts MS. Deficiencies of cardiovascular risk prediction models for type 1 diabetes. Diabetes Care. 2006;29(8):1860-1865. doi:10.2337/dc06-0290

Saldanha De Mattos Matheus A, Brito Gomes M. Early aggressive macrovascular disease and type 1 diabetes mellitus without chronic complications: A case report. BMC Research Notes. 2013;6(1). doi:10.1186/1756-0500-6-222

Orchard TJ, Costacou T, Kretowski A, Nesto RW. Type 1 diabetes and coronary artery disease. Diabetes Care. 2006;29(11):2528-2538. doi:10.2337/dc06-1161

Saberzadeh-Ardestani B, Karamzadeh R, Basiri M, et al. Type 1 diabetes mellitus: Cellular and molecular pathophysiology at a glance. Cell Journal. 2018;20(3):294-301. doi:10.22074/cellj.2018.5513

Walsh MG, Zgibor J, Borch-Johnsen K, Orchard TJ. A Multinational Comparison of Complications Assessment in Type 1 Diabetes The DiaMond Substudy of Complications (DiaComp) Level 2 ON BEHALF OF THE DIACOMP INVESTIGATORS*.; 2004.

Snell-Bergeon JK, Roman R, Rodbard D, et al. Glycaemic variability is associated with coronary artery calcium in men with Type 1 diabetes: The coronary artery calcification in Type 1 diabetes study. Diabetic Medicine. 2010;27(12):1436-1442. doi:10.1111/j.1464-5491.2010.03127.x

Sousa GR, Pober D, Galderisi A, et al. Glycemic control, cardiac autoimmunity, and long-term risk of cardiovascular disease in type 1 diabetes mellitus A DCCT/EDIC cohort–based study. Circulation. 2019;139(6):730-743. doi:10.1161/CIRCULATIONAHA.118.036068

Sharma H, Lencioni M, Narendran P. Cardiovascular disease in type 1 diabetes. Cardiovascular Endocrinology and Metabolism. 2019;8(1):28-34. doi:10.1097/XCE.0000000000000167

Orchard TJ, Costacou T, Kretowski A, Nesto RW. Type 1 diabetes and coronary artery disease. Diabetes Care. 2006;29(11):2528-2538. doi:10.2337/dc06-1161

Miettinen H, Lehto S, Salomaa V, et al. Impact of diabetes on mortality after the first myocardial infarction. Diabetes Care. 1998;21(1):69-75. doi:10.2337/diacare.21.1.69

Vinik AI, Ziegler D. Diabetic cardiovascular autonomic neuropathy. Circulation. 2007;115(3):387-397. doi:10.1161/CIRCULATIONAHA.106.634949

Bissinger A. Cardiac Autonomic Neuropathy: Why Should Cardiologists Care about That? Journal of Diabetes Research. 2017;2017. doi:10.1155/2017/5374176

Colhoun HM, Francis DP, Rubens MB, Underwood SR, Fuller JH. The Association of Heart-Rate Variability With Cardiovascular Risk Factors and Coronary Artery Calcification A Study in Type 1 Diabetic Patients and the General Population.

Pop-Busui R, Braffett BH, Zinman B, et al. Cardiovascular autonomic neuropathy and cardiovascular outcomes in the diabetes control and complications trial/ epidemiology of diabetes interventions and complications (DCCT/EDIC) Study. Diabetes Care. 2017;40(1):94-100. doi:10.2337/dc16-1397

Gomes MB, Cobas RA, Nunes E, et al. Plasma PAF-acetylhydrolase activity, inflammatory markers and susceptibility of LDL to in vitro oxidation in patients with type 1 diabetes mellitus. Diabetes Research and Clinical Practice. 2009;85(1):61-68. doi:10.1016/j.diabres.2009.04.016

Beckman JA, Creager MA, Libby P. Diabetes and Atherosclerosis Epidemiology, Pathophysiology, and Management. http://jama.jamanetwork.com/

Rodrigues TC, Snell-Bergeon JK, Maahs DM, Kinney GL, Rewers M. Higher Fibrinogen Levels Predict Progression of Coronary Artery Calcification in Adults with Type 1 Diabetes. Atherosclerosis. 2010;210(2):671-673. doi:10.1016/j.atherosclerosis.2009.12.034

Lopes-Virella MF, Bebu I, Hunt KJ, et al. Immune complexes and the risk of CVD in type 1 diabetes. Diabetes. 2019;68(9):1853-1860. doi:10.2337/db19-0358

Basu A, Jenkins AJ, Zhang Y, et al. Data on carotid intima-media thickness and lipoprotein subclasses in type 1 diabetes from the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC). Data in Brief. 2016;6:33-38. doi:10.1016/j.dib.2015.11.036

Hunt KJ, Baker N, Cleary P, et al. Oxidized LDL and AGE-LDL in circulating immune complexes strongly predict progression of carotid artery IMT in type 1 diabetes. Atherosclerosis. 2013;231(2):315-322. doi:10.1016/j.atherosclerosis.2013.09.027

Devaraj S, Cheung AT, Jialal I, et al. Evidence of increased inflammation and microcirculatory abnormalities in patients with type 1 diabetes and their role in microvascular complications. Diabetes. 2007;56(11):2790-2796. doi:10.2337/db07-0784

Harding SA, Sommerfield AJ, Sarma J, et al. Increased CD40 ligand and platelet-monocyte aggregates in patients with type 1 diabetes mellitus. Atherosclerosis. 2004;176(2):321-325. doi:10.1016/j.atherosclerosis.2004.05.008

Hokanson JE, Cheng S, Snell-Bergeon JK, et al. A Common Promoter Polymorphism in the Hepatic Lipase Gene (LIPC-480C>T) Is Associated With an Increase in Coronary Calcification in Type 1 Diabetes. Vol 51.; 2002.

Simpson M, Snell-Bergeon JK, Kinney GL, et al. Haptoglobin Genotype Predicts Development of Coronary Artery Calcification in a Prospective Cohort of Patients with Type 1 Diabetes.; 2011. http://www.cardiab.com/content/10/1/99

Söderlund J, Forsblom C, Ilonen J, et al. HLA class II is a factor in cardiovascular morbidity and mortality rates in patients with type 1 diabetes. Diabetologia. 2012;55(11):2963-2969. doi:10.1007/s00125-012-2670-6

Dabelea D, Kinney G, Snell-Bergeon JK, et al. Effect of Type 1 Diabetes on the Gender Difference in Coronary Artery Calcification: A Role for Insulin Resistance? The Coronary Artery Calcification in Type 1 Diabetes (CACTI) Study.; 2003.

Holt RIG, DeVries JH, Hess-Fischl A, et al. The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2021;64(12):2609-2652. doi:10.1007/s00125-021-05568-3




DOI: https://doi.org/10.21776/ub.hsj.2022.003.03.2

Refbacks

  • There are currently no refbacks.


Copyright (c) 2022 Dyah Ayu Ikeningrum, Djanggan Sargowo, Novi Kurnianingsih, Anna Fuji Rahimah

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.